Antidepressant potential of metabotropic glutamate receptor mGlu2 and mGlu3 negative allosteric modulators

被引:13
|
作者
Joffe, Max E. [1 ,2 ,3 ]
Conn, P. Jeffrey [1 ,2 ,3 ]
机构
[1] Vanderbilt Univ, Dept Pharmacol, Nashville, TN 37232 USA
[2] Vanderbilt Ctr Neurosci Drug Discovery, Nashville, TN 37232 USA
[3] Vanderbilt Ctr Addict Res, Nashville, TN 37232 USA
基金
美国国家卫生研究院;
关键词
DESIGN;
D O I
10.1038/s41386-018-0192-8
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
引用
收藏
页码:214 / 215
页数:2
相关论文
共 50 条
  • [41] Activation of mGlu2 receptors mediates the "antipsychotic-like" activity of mGlu2/3 receptor agonists in three psychotomimetic drug models and regional distribution of mGlu2 vs. mGlu3 receptors
    Marek, G. J.
    Wright, R. A.
    Johnson, B. G.
    Fell, M.
    Svensson, K.
    Benvenga, M.
    Chaney, S.
    Schoepp, D. D.
    Monn, J.
    NEUROPHARMACOLOGY, 2008, 55 (04) : 608 - 609
  • [42] Structure-activity relationship for novel agonists of metabotropic glutamate receptors mGlu2 and mGlu3.
    Massey, SM
    Valli, MJ
    Prieto, L
    Bick, PJ
    Bures, M
    Andis, SL
    Wright, RA
    Johnson, BG
    Schoepp, DD
    Monn, JA
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2002, 224 : U51 - U51
  • [43] Structures of Gi-bound metabotropic glutamate receptors mGlu2 and mGlu4
    Lin, Shuling
    Han, Shuo
    Cai, Xiaoqing
    Tan, Qiuxiang
    Zhou, Kexiu
    Wang, Dejian
    Wang, Xinwei
    Du, Juan
    Yi, Cuiying
    Chu, Xiaojing
    Dai, Antao
    Zhou, Yan
    Chen, Yan
    Zhou, Yu
    Liu, Hong
    Liu, Jianfeng
    Yang, Dehua
    Wang, Ming-Wei
    Zhao, Qiang
    Wu, Beili
    NATURE, 2021, 594 (7864) : 583 - +
  • [44] Discovery of Novel mGlu3-Selective Allosteric Modulators Provides New Insights Into mGlu3 Function
    Lindsley, Craig
    CURRENT NEUROPHARMACOLOGY, 2014, 12 : 35 - 36
  • [45] A combination of flow and batch mode processes for the efficient preparation of mGlu2/3 receptor negative allosteric modulators (NAMs)
    Dhanya, Raveendra Panickar
    Herath, Ananda
    Sheffler, Douglas J.
    Cosford, Nicholas D. P.
    TETRAHEDRON, 2018, 74 (25) : 3165 - 3170
  • [46] Deletion of Metabotropic Glutamate Receptors 2 and 3 (mGlu2 & mGlu3) in Mice Disrupts Sleep and Wheel-Running Activity, and Increases the Sensitivity of the Circadian System to Light
    Pritchett, David
    Jagannath, Aarti
    Brown, Laurence A.
    Tam, Shu K. E.
    Hasan, Sibah
    Gatti, Silvia
    Harrison, Paul J.
    Bannerman, David M.
    Foster, Russell G.
    Peirson, Stuart N.
    PLOS ONE, 2015, 10 (05):
  • [47] Metabotropic glutamate2/3 (mGlu2/3) receptors, schizophrenia and cognition
    Marek, Gerard J.
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2010, 639 (1-3) : 81 - 90
  • [48] Structures of Gi-bound metabotropic glutamate receptors mGlu2 and mGlu4
    Shuling Lin
    Shuo Han
    Xiaoqing Cai
    Qiuxiang Tan
    Kexiu Zhou
    Dejian Wang
    Xinwei Wang
    Juan Du
    Cuiying Yi
    Xiaojing Chu
    Antao Dai
    Yan Zhou
    Yan Chen
    Yu Zhou
    Hong Liu
    Jianfeng Liu
    Dehua Yang
    Ming-Wei Wang
    Qiang Zhao
    Beili Wu
    Nature, 2021, 594 : 583 - 588
  • [49] A group II metabotropic glutamate receptor 3 (mGlu3, GRM3) isoform implicated in schizophrenia interacts with canonical mGlu3 and reduces ligand binding
    Garcia-Bea, Aintzane
    Bermudez, Isabel
    Harrison, Paul J.
    Lane, Tracy A.
    JOURNAL OF PSYCHOPHARMACOLOGY, 2017, 31 (12) : 1519 - 1526
  • [50] Targeting Group II Metabotropic Glutamate (mGlu) Receptors for the Treatment of Psychosis Associated with Alzheimer's Disease: Selective Activation of mGlu2 Receptors Amplifies β-Amyloid Toxicity in Cultured Neurons, Whereas Dual Activation of mGlu2 and mGlu3 Receptors Is Neuroprotective
    Caraci, Filippo
    Molinaro, Gemma
    Battaglia, Giuseppe
    Giuffrida, Maria Laura
    Riozzi, Barbara
    Traficante, Anna
    Bruno, Valeria
    Cannella, Milena
    Merlo, Sara
    Wang, Xushan
    Heinz, Beverly A.
    Nisenbaum, Eric S.
    Britton, Thomas C.
    Drago, Filippo
    Sortino, Maria Angela
    Copani, Agata
    Nicoletti, Ferdinando
    MOLECULAR PHARMACOLOGY, 2011, 79 (03) : 618 - 626